WJOG6510G: Randomized phase II of Pmab + IRI vs Cmab + IRI for KRAS WT mCRC previously treated after FU, IRI, and L-OHP

Hiroki Hara, Daisuke Sakai, Toshimi Takano, Katsunori Shinozaki, Masahiro Goto, Hiroya Taniguchi, Junji Kishimoto, Narikazu Boku, Ichinosuke Hyodo, Kei Muro

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)ix74
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume28
DOIs
Publication statusPublished - Oct 1 2017

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this